Back to LYEL

ARCH Venture Management, LLC → LYEL

ARCH Venture Management, LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
4
Latest value
$31.8M
Q3 2026
Peak value
$84.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$84.9M
Q1 2026$65.1M
Q2 2026$45.5M
Q3 2026$31.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$31.8M3.25M——
Q2 2026$45.5M3.25M——
Q1 2026$65.1M3.25M——
Q4 2025$84.9M2.76M——

Other funds holding LYEL

Other ARCH Venture Management, LLC positions

PBLS

PARABILIS MEDICINES INC

$207.1M
PBLS

PARABILIS MEDICINES INC

$175.5M
MAZE

MAZE THERAPEUTICS INC.

$170.7M
BEAM

BEAM THERAPEUTICS INC

$155.8M
RAPP

RAPPORT THERAPEUTICS INC

$155.4M
VIR

VIR BIOTECHNOLOGY INC

$141.9M
SPTX

SEAPORT THERAPEUTICS INC

$136.6M
SANA

SANA BIOTECHNOLOGY INC

$133.7M